| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.6 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.59 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.36 | 0.004 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |